| Predicate | Object |
|---|---|
| rdf:type | |
| entrezgene:geneRifText |
Selective ETAR antagonism by ZD4054 displays antitumoral activity on breast cancer cells in vitro and in vivo. Data strongly support a rationale for the clinical use of ZD4054 in combination with endocrine therapies.
|